PML in a Patient Treated with Fumaric Acid

被引：139

作者：

Ermis, Ummehan ^{[1
]}

Weis, Joachim ^{[1
]}

Schulz, Joerg B. ^{[1
]}

机构：

[1] Rhein Westfal TH Aachen, D-52062 Aachen, Germany

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 17期

关键词：

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

D O I：

10.1056/NEJMc1211805

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：1657 / 1658

页数：2

相关论文

共 3 条

[1]

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy [J].

Bloomgren, Gary ;

Richman, Sandra ;

Hotermans, Christophe ;

Subramanyam, Meena ;

Goelz, Susan ;

Natarajan, Amy ;

Lee, Sophia ;

Plavina, Tatiana ;

Scanlon, James V. ;

Sandrock, Alfred ;

Bozic, Carmen .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20) :1870-1880

[2]

Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases [J].

Harries, MJ ;

Chalmers, RJG ;

Griffiths, CEM .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :549-551

[3]

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis [J].

Schroeder, Alexandra ;

Lee, De-Hyung ;

Hellwig, Kerstin ;

Lukas, Carsten ;

Linker, Ralf A. ;

Gold, Ralf .

ARCHIVES OF NEUROLOGY, 2010, 67 (11) :1391-1394